YU109590A - Proteini, vakcine i nukleinske kiseline - Google Patents

Proteini, vakcine i nukleinske kiseline

Info

Publication number
YU109590A
YU109590A YU109590A YU109590A YU109590A YU 109590 A YU109590 A YU 109590A YU 109590 A YU109590 A YU 109590A YU 109590 A YU109590 A YU 109590A YU 109590 A YU109590 A YU 109590A
Authority
YU
Yugoslavia
Prior art keywords
protein
vaccines
proteins
nucleic acids
tbe
Prior art date
Application number
YU109590A
Other languages
English (en)
Inventor
F.X. Heinz
C.W. Mandl
C. Kunz
F. Dorner
W. Bodemer
G. Antoine
Original Assignee
Immuno Ag. Fuer Chemisch Medizintsche Produkte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag. Fuer Chemisch Medizintsche Produkte filed Critical Immuno Ag. Fuer Chemisch Medizintsche Produkte
Publication of YU109590A publication Critical patent/YU109590A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PROTEINI, VAKCINE I NUKLEINSKE KISELINE. Opisana je sekvenca nukleotida i aminokiselinska sekvenca NS-1 proteina zapadnog subtipa krpeljskog virusa izazivača encefalitisa (TBE). Sekvenca je izvedena iz cDNK klonova. NS-1 protein se može upotrebiti kao konstituent TBE vakcine, kao dijagnostički reagens ili za druge svrhe. Kodirajuća nukleinska kiselina za NS-1 protein se može upotrebiti za generisanje ekspresionih sistema ili za pripremanje žive vakcine.
YU109590A 1989-06-06 1990-06-05 Proteini, vakcine i nukleinske kiseline YU109590A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89305708 1989-06-06

Publications (1)

Publication Number Publication Date
YU109590A true YU109590A (sh) 1992-07-20

Family

ID=8202711

Family Applications (1)

Application Number Title Priority Date Filing Date
YU109590A YU109590A (sh) 1989-06-06 1990-06-05 Proteini, vakcine i nukleinske kiseline

Country Status (12)

Country Link
EP (1) EP0402116B1 (sh)
JP (1) JPH03151878A (sh)
AT (1) ATE143373T1 (sh)
CA (1) CA2018332A1 (sh)
CZ (1) CZ277921B6 (sh)
DD (1) DD297997A5 (sh)
DE (1) DE69028658T2 (sh)
FI (1) FI902814A0 (sh)
HU (1) HUT54306A (sh)
NO (1) NO902491L (sh)
SK (1) SK277781B6 (sh)
YU (1) YU109590A (sh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4224402A1 (de) * 1992-07-21 1994-01-27 Schering Ag Neue Pyridin-Derivate mit Leukotrien-B¶4¶-antagonistischer Wirkung
FR2794865B1 (fr) 1999-06-09 2003-04-18 Pasteur Institut Methode de detection precoce des flavivirus et ses applications

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3853693D1 (de) * 1987-03-20 1995-06-08 Immuno Ag DNA- und RNA-Moleküle des westlichen Subtyps des FSME-Virus, Polypeptide, die von diesen Molekülen codiert werden, und deren Verwendung.
IL91304A0 (en) * 1988-08-20 1990-03-19 Us Health Recombinant vaccinia virus for prevention of disease caused by flavivirus

Also Published As

Publication number Publication date
DE69028658T2 (de) 1997-03-06
NO902491L (no) 1990-12-07
DD297997A5 (de) 1992-01-30
FI902814A0 (fi) 1990-06-05
HU903490D0 (en) 1990-10-28
HUT54306A (en) 1991-02-28
CZ277921B6 (en) 1993-06-16
JPH03151878A (ja) 1991-06-28
CA2018332A1 (en) 1990-12-06
NO902491D0 (no) 1990-06-05
CS9002806A2 (en) 1991-11-12
DE69028658D1 (de) 1996-10-31
ATE143373T1 (de) 1996-10-15
EP0402116A1 (en) 1990-12-12
SK277781B6 (en) 1995-01-05
EP0402116B1 (en) 1996-09-25

Similar Documents

Publication Publication Date Title
DK84194A (da) Rekombinant hepatitis B-virus DNA-molekyler, værtsorganismer transformeret hermed, HBV-antigenetiske polypeptider, DNA-sekvenser kodende herfor, fremgangsmåder til påvisning af hepatitis B-virus antistoffer i blodserum, fremgangsmåder til fremstilling af nævnte DNA-molekyler, fremgangsmåder til fremstilling af nævnte polypeptider, midler til påvisn
HUP0002176A2 (hu) Vakcinákban vagy diagnosztikai vizsgálatokban alkalmazható PRRSV-peptidszekvenciákat azonosító PRRSV-antigénhelyek
DK0561890T3 (da) DNA ekspressionssystemer baseret på alphavira
ATE325882T1 (de) Polypeptide, die mit alfalfamosaikviralen oder ilarviralen kapsiden fusioniert sind
Kilbourne et al. Influenza Virus Polypeptides and Antigens: Summary of Influeza Workshop I
DK0644202T3 (da) Syntetiske antigener til påvisning af antistoffer imod hepatitis C virus
BR0012919A (pt) Vacina para uso na profilaxia e/ou no tratamento da sìndrome de ponto branco (white spot syndrome) em crustáceos, proteìna estrutural derivada do vìrus da sìndrome de ponto branco, sequência de ácido nucléico, uso de uma proteìna estrutural, composição farmacêutica, anticorpos, vacina ou formulação farmacêutica, e, kit diagnóstico para detecção de wssv
SG144692A1 (en) Antigenic proteins of shrimp white spot syndrome virus and uses thereof
ATE355375T1 (de) Bakterioferritin aus helicobacter pylori
Blok et al. Block deletions in the neuraminidase genes from some influenza A viruses of the N1 subtype
YU109590A (sh) Proteini, vakcine i nukleinske kiseline
IE870507L (en) Bovine virus diarrhea and hog cholera vaccines
ES2057579T3 (es) Peptidos e1 y c de rubeola.
BR0110384A (pt) Usos de uma proteina ns1 e/ou ns2 do rsv ou de uma sequência de ácido nucléico e de um rsv recombinante, método para alterar o espectro de hospedeiro do rsv, rsv recombinante, e, vìrus recombinante
FI950248A (fi) Rokotteita monisoluisia loisia vastaan
Mosser et al. Proteins of Rous-associated virus type 61: polypeptide stoichiometry and evidence that glycoprotein gp35 is not a cleavage product of gp85
DK0426314T3 (da) HIV-relaterede peptider
YU48126B (sh) Postupak za pripremanje proteina plasmodium falciparum-a
AR110104A1 (es) Secuencias potenciadoras de la expresión de proteína y su uso
TH50271A3 (th) เพสทิไวรัสที่ไม่แผ่กระจาย
RS50013B (sr) Himerni gen koji kodira antigene determinante četiri proteina l.infantum
SG145521A1 (en) Synthetic antigens for the detection of antibodies to hepatitis c virus